Town & Country Bank & Trust CO dba First Bankers Trust CO acquired a new stake in AstraZeneca PLC (OTCMKTS:AZNCF – Free Report) in the 1st quarter, HoldingsChannel reports. The institutional investor acquired 6,851 shares of the company’s stock, valued at approximately $1,351,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vaughan David Investments LLC IL purchased a new position in AstraZeneca in the 4th quarter valued at $88,367,000. Captrust Financial Advisors purchased a new stake in shares of AstraZeneca during the fourth quarter worth $24,965,000. Azimuth Capital Investment Management LLC acquired a new stake in shares of AstraZeneca in the fourth quarter valued at about $20,440,000. L & S Advisors Inc acquired a new stake in shares of AstraZeneca in the fourth quarter valued at about $14,863,000. Finally, Park National Corp OH purchased a new position in shares of AstraZeneca in the first quarter worth about $14,462,000. Hedge funds and other institutional investors own 40.87% of the company’s stock.
AstraZeneca Price Performance
OTCMKTS:AZNCF opened at $187.10 on Monday. AstraZeneca PLC has a twelve month low of $122.26 and a twelve month high of $195.00. The company’s 50-day moving average price is $187.10 and its 200-day moving average price is $186.05.
About AstraZeneca
AstraZeneca (OTCMKTS:AZNCF) is a global biopharmaceutical company that focuses on the discovery, development, manufacturing and commercialization of prescription medicines. The company’s research and development efforts are concentrated in three main therapeutic areas: oncology; cardiovascular, renal and metabolism; and respiratory, inflammation and autoimmunity. AstraZeneca’s product portfolio includes targeted therapies for lung and breast cancers, novel agents for heart failure and chronic kidney disease, and inhaled treatments for asthma and chronic obstructive pulmonary disease.
The company was formed in 1999 through the merger of Sweden’s Astra AB and the United Kingdom’s Zeneca Group, creating one of the world’s largest pharmaceutical firms.
See Also
- Five stocks we like better than AstraZeneca
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Want to see what other hedge funds are holding AZNCF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AstraZeneca PLC (OTCMKTS:AZNCF – Free Report).
Receive News & Ratings for AstraZeneca Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca and related companies with MarketBeat.com's FREE daily email newsletter.
